CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This research aims to develop new treatments for cancer and cardiovascular diseases by exploring the functions of endothelial growth factors. It seeks to create preclinical models that enhance understanding of blood vessel growth and its implications for therapy, leveraging advanced genetic and molecular techniques.
This application promises to provide new treatment options for cancer and cardiovascular diseases that are the leading causes of morbidity and mortality in the western world.
Current cardiovascular and cancer therapies are often insufficient, unsuccessful or not suitable for all patients.
Inhibition of angiogenesis is already used in the clinics, but with limited success.
On the other hand, stimulation of the growth of blood vessels, angiogenesis, and of arteriogenesis, the growth of (collateral…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
